Paper32065026
Estimating Social Variation in the Health Effects of Changes in Health Care Expenditure.
Love-Koh J and 3 others. Med Decis Making, 2020. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Estimating Social Variation in the Health Effects of Changes in Health Care Expenditure. Papers, record 32065026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32065026
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Health Expenditures | Major topic |
| Health Status Disparities | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Child | |
| Child, Preschool | |
| England | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Middle Aged | |
| Organizational Case Studies | |
| Quality-Adjusted Life Years | |
| Socioeconomic Factors | |
| State Medicine | |
| Young Adult |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25908564 | Distributional Cost-Effectiveness Analysis: A Tutorial. | Med Decis Making | 2016 | https://conductscience.org/library/papers/25908564 | PubMed |
| 2 | 10544328 | Health care spending as determinants of health outcomes. | Health Econ | 1999 | https://conductscience.org/library/papers/10544328 | PubMed |
| 3 | 18767897 | Valuing health States for use in cost-effectiveness analysis. | Pharmacoeconomics | 2008 | https://conductscience.org/library/papers/18767897 | PubMed |
| 4 | 26787198 | How a universal health system reduces inequalities: lessons from England. | J Epidemiol Community Health | 2016 | https://conductscience.org/library/papers/26787198 | PubMed |
| 5 | 18767894 | The NICE cost-effectiveness threshold: what it is and what that means. | Pharmacoeconomics | 2008 | https://conductscience.org/library/papers/18767894 | PubMed |
| 6 | 25488707 | Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients? | Health Econ | 2015 | https://conductscience.org/library/papers/25488707 | PubMed |
| 7 | 25692211 | Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. | Health Technol Assess | 2015 | https://conductscience.org/library/papers/25692211 | PubMed |
| 8 | 32441558 | Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts. | Med Decis Making | 2020 | https://conductscience.org/library/papers/32441558 | PubMed |
| 9 | 15483304 | Measures of health inequalities: part 2. | J Epidemiol Community Health | 2004 | https://conductscience.org/library/papers/15483304 | PubMed |
| 10 | 28237196 | Using Cost-Effectiveness Analysis to Address Health Equity Concerns. | Value Health | 2017 | https://conductscience.org/library/papers/28237196 | PubMed |
| 11 | 31511189 | Estimating the Marginal Productivity of the English National Health Service From 2003 to 2012. | Value Health | 2019 | https://conductscience.org/library/papers/31511189 | PubMed |
| 12 | 28462255 | Does More Public Health Spending Buy Better Health? | Health Serv Res Manag Epidemiol | 2015 | https://conductscience.org/library/papers/28462255 | PubMed |
| 13 | 31386646 | Assessment of Inequality Alongside Policy-oriented Trials: An Empirical Framework Based on the Case of Screening. | Epidemiology | 2019 | https://conductscience.org/library/papers/31386646 | PubMed |
| 14 | 16429295 | The relationship between health care expenditure and health outcomes. Evidence and caveats for a causal link. | Eur J Health Econ | 2006 | https://conductscience.org/library/papers/16429295 | PubMed |
| 15 | 30483412 | Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. | BMJ Glob Health | 2018 | https://conductscience.org/library/papers/30483412 | PubMed |
| 16 | 24865459 | The impact of NHS resource allocation policy on health inequalities in England 2001-11: longitudinal ecological study. | BMJ | 2014 | https://conductscience.org/library/papers/24865459 | PubMed |
| 17 | 3499669 | International cross-section analysis of the determination of mortality. | Soc Sci Med | 1987 | https://conductscience.org/library/papers/3499669 | PubMed |
| 18 | 24811892 | NICE's cost-effectiveness range: should it be lowered? | Pharmacoeconomics | 2014 | https://conductscience.org/library/papers/24811892 | PubMed |
| 19 | 29273843 | Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. | Pharmacoeconomics | 2018 | https://conductscience.org/library/papers/29273843 | PubMed |
| 20 | 711980 | Health service 'input' and mortality 'output' in developed countries. | J Epidemiol Community Health (1978) | 1978 | https://conductscience.org/library/papers/711980 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41539560 | Value-Based Pricing of Health Services With Health Equity Considerations. | Value Health | 2026 | https://conductscience.org/library/papers/41539560 | PubMed |
| 41533281 | A Method for Comparing Health Inequality Impact Magnitudes, with an Illustration for Hypothetical Treatments of 1336 Diseases. | Pharmacoeconomics | 2026 | https://conductscience.org/library/papers/41533281 | PubMed |
| 40329067 | Aggregate Distributional Cost-Effectiveness Analysis of Biologics for the Treatment of Ankylosing Spondylitis in Chile. | Appl Health Econ Health Policy | 2025 | https://conductscience.org/library/papers/40329067 | PubMed |
| 39327612 | Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia. | Glob Health Res Policy | 2024 | https://conductscience.org/library/papers/39327612 | PubMed |
| 39261579 | Impact of Diagnosis-Related Groups (DRG) reform on cost homogeneity of treatment for patients with malignant tumours. | Sci Rep | 2024 | https://conductscience.org/library/papers/39261579 | PubMed |
| 38758291 | Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework. | Pharmacoeconomics | 2024 | https://conductscience.org/library/papers/38758291 | PubMed |
| 38555401 | An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/38555401 | PubMed |
| 38448909 | An empirical ethics study of the coherence of NICE technology appraisal policy and its implications for moral justification. | BMC Med Ethics | 2024 | https://conductscience.org/library/papers/38448909 | PubMed |
| 37296369 | Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers. | Pharmacoeconomics | 2023 | https://conductscience.org/library/papers/37296369 | PubMed |
| 37221341 | Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration. | Appl Health Econ Health Policy | 2023 | https://conductscience.org/library/papers/37221341 | PubMed |
| 36612824 | Challenges and Limitations in Distributional Cost-Effectiveness Analysis: A Systematic Literature Review. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/36612824 | PubMed |
| 35767187 | Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study. | Appl Health Econ Health Policy | 2022 | https://conductscience.org/library/papers/35767187 | PubMed |
| 35493397 | Spatial and Temporal Differences in the Health Expenditure Efficiency of China: Reflections Based on the Background of the COVID-19 Pandemic. | Front Public Health | 2022 | https://conductscience.org/library/papers/35493397 | PubMed |
| 35173023 | Innovations in cost-effectiveness analysis that advance equity can expand its use in health policy. | BMJ Glob Health | 2022 | https://conductscience.org/library/papers/35173023 | PubMed |
| 34098791 | Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions. | Med Decis Making | 2021 | https://conductscience.org/library/papers/34098791 | PubMed |
| 32608317 | Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis. | Med Decis Making | 2020 | https://conductscience.org/library/papers/32608317 | PubMed |
| 32291596 | Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations. | Pharmacoeconomics | 2020 | https://conductscience.org/library/papers/32291596 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DLAT | 1737 | PubTator's text mining | https://conductscience.org/library/genes/1737 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32065026
GET https://conductscience.org/api/papers/v1/32065026/references?page=2